Short-course radiation for early vocal cord cancer
Part of Cancer clinical trials.
This trial tests a shorter course of radiation therapy for early-stage vocal cord cancer. The aim is to see if giving slightly higher doses per session (3.5 Gy) is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of squamous cell carcinoma of the glottis, which is a type of cancer on your vocal cords.
- Your cancer is at an early stage (T1 or T2) and has not spread to lymph nodes or other parts of the body.
- You are 18 years of age or older and have a performance status (how well you can do daily activities) of 0-2 on the ECOG scale.
- You have not had previous radiation therapy or surgery to your larynx (voice box), unless it was just a biopsy.
- Your overall health is good enough to have a life expectancy of at least 6 months, and you can attend follow-up visits and complete voice assessments.
- You must sign a consent form agreeing to participate in the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a shorter course of radiation (hypofractionated) works as well as the standard longer course for people with early-stage cancer of the vocal cords. The goal is to find a treatment that is more convenient and has similar results.
This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.
This trial compares two treatments—CO2 laser surgery through the mouth versus one-vocal-cord irradiation—for early-stage larynx (voice box) cancer. It aims to see which option better preserves voice quality after treatment.
This study tests a precise, MRI-guided radiation treatment for early-stage vocal cord cancer. It aims to deliver high-dose radiation more accurately to the tumor, possibly reducing side effects and improving outcomes.
This study compares two standard treatments for early-stage cancer in the upper part of the voice box (supraglottic larynx) that hasn't spread to neck lymph nodes: radiation therapy versus surgical removal of the neck lymph nodes. The goal is to see which approach better controls the cancer while preserving quality of life.
This study tests whether a shorter course of radiation therapy after robotic surgery for HPV-related throat cancer is as effective as the usual longer course. It aims to reduce side effects while maintaining good outcomes.
Hear when a new Early Glottic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.